Starting with Exelixis’ condition on in-house dispensing data, manufacturers are introducing a new approach to 340B claims focused on transparency.
|Articles|October 11, 2004
Cr?me De La Cr?me
Who are the shining lights among independent pharmacies for 2004? Once again, Drug Topics invited wholesalers across the country to nominate their independent pharmacy customers who have done a superlative job of providing pharmacy and nonpharmacy services, merchandising or promoting their stores, overcoming competition, and handling crises.
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Drug Topics
1
GLP-1 Therapy Must Prioritize Metabolic Quality Over Weight Loss
2
COVID-19 Vaccine Hesitancy in 2026: How Attitudes Have Shifted
3
PPV23 Vaccination Found to Not Reduce Cardiovascular Risk
4
Social Media Best Practices for Pharmacists: Why Visibility Matters
5